Clinical Trials Browser

Phase 1 × ridaforolimus × Sarcoma × Clear all

NCT00087451 2015-08-19

Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)

Phase 1 Completed

Glioblastoma, Glioma, Gliosarcoma

NCT00288431 2015-07-22

Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)

Phase 1 Completed

Neoplasms, Sarcoma